Anti-BPI is an ELISA-based, automated, in-vitro test system for the quantitative determination of IgG antibodies against bactericidal permeability-increasing protein BPI in human serum or plasma.

Antineutrophil cytoplasmic antibodies (cANCA) against bactericidal permeability-increasing protein (BPI), in addition to PR3 or MPO antibodies, are important serological markers in the diagnosis of a number of inflammatory, especially rheumatic and gastrointestinal diseases. Antibodies against BPI are primarily found in patients with cystic fibrosis and in patients with chronic inflammatory intestinal conditions like Crohn’s disease and ulcerative colitis. Anti-PR3-negative serum samples that display a typical cANCA pattern in their immunofluorescence test should be tested for BPI antibodies.


Product Number ORG 223
Tests24 Alegria® strips
Range0 - 100 U/ml
Cut-off10 U/ml
Coating bactericidal permeability-increasing protein (BPI) (human)

ORG 523   ORG 530  


Instruction for Use
Safety Data Sheet

Document Archive
Instruction for Use Revision 4. Earlier versions and additional languages can be found in the document archive.
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok